September Waiting Times Data Release

Updated: Nov 14, 2019

September National Provider Data Summary

  • At the end of September 2018, 86.7% of patients waiting to start treatment(incomplete pathways) were waiting up to 18 weeks, thus not meeting the 92% standard.

  • The number of RTT patients waiting to start treatment at the end of September 2018 was 4.1 million patients. Of those, 3,156 patients were waiting more than 52 weeks.

  • For patients waiting to start treatment at the end of September 2018, the median waiting time was 7.6 weeks. The 92nd percentile waiting time was 22.2 weeks.

  • During September 2018, 284,098 RTT patients started admitted treatment and 1,008,885 started non-admitted treatment (completed pathways).

RTT Performance

As the below heatmap and graph shows, there has been a substantial deterioration in RTT performance nationally when compared to September 2017.



Waiting List Size

As the below graph demonstrates, from March 2018 to September 2018 the total waiting list size increased from 3,843,182 to 4,128,538, an increase of 285,365 (7.42%).


For the first time since January 2018, and more importantly, for the first time since March 2018, the waiting list size has decreased, going from 4,154,559 in August to 4,128,538 in September, a decrease of 260,21 pathways (0.62%).


Below is a table showing each reporting Trusts variance in waiting list size from March 2018 to September 2018, sorted by percentage variance (please click to view the whole table).


52 Week Waiters

The below heatmap shows how the number of 52-week waiters has changed nationally, with some areas such as the South West suffering a significant increase, but other areas such as the East Midlands managing to reduce their number of 52-week waiters.

Below is a table showing each reporting Trust’s variance in 52-week waiters from March 2018 to September 2018, sorted by percentage variance (please click to view the whole table).


Changes to the Individual Specialties

In regard to the waiting list size of the individual specialties:


  • Geriatric Medicine saw the highest percentage decrease, going from 22,022 to 21,207 a decrease of 815 pathways (3.70%), however Other saw the highest decrease in pathways going from 848,525 to 837,395 a decrease of 11,130 pathways (1.31%).

  • Thoracic Medicine also saw a decrease in the waiting list size going from 97,991 to 95,239, a decrease of 2,752 pathways (2.80%).

  • Plastic Surgery and Neurology both saw a percentage increase in the waiting list size. Plastic Surgery going from 50,870 to 51,322, an increase of 452 pathways (0.88%) and Neurology going from 123,121 to 124,162, an increase of 1,041 pathways (0.84%).

  • Dermatology, as a single specialty saw the highest percentage increase in the waiting list size as well as the largest increase of pathways, going from 223,746 to 227,080, an increase of 3,334 pathways (1.49%).


Summary

Whilst RTT performance continues to deteriorate, the decrease in the waiting list size provides a glimmer of hope for achievement of the March 2019 targets. However, perhaps this is the calm before the inevitable storm of winter pressures.